Executive Board

Jan Törnell, Chairman of the Board, Chairman, MD, PhD, Prof.

Former VP strategy oncology and infection, Astra Zeneca. Several board assignments in listed and private pharmaceutical companies

Anders Bjartell, Board Member, MD, PhD, Prof.

Chief of urology at Skåne University Hospital since 2006. PhD in Medical cell research. European specialist degree in Urology. Responsible for clinical trials in prostate cancer at the urology clinic SUS Malmö since 2007. Research group leader for urological cancer research at the Institute for Translational Medicine at Lund University. Published over 200 original scientific articles.

Daniel Lifveredson, Board Member, MSc

CEO/Owner of Excore. Investor (and in some cases board member) in several public and private pharmaceutical companies. 

Stefan Rehnmark, Board Member, PhD, Prof

More than 20 years in Biotech industry, holding several positions, such as line manager, project manager, VP, CSO and CEO. Co-founder of 2 Biotech companies.